Allegra Rollo
@allegrarollo
MD Candidate @BrownMedicine via @HarvardHEB and gyn onc consulting. Tweets are my own.
ID: 1418232521041514500
22-07-2021 15:32:45
30 Tweet
66 Takipçi
229 Takip Edilen
Three voluntary withdrawals of PARPi tx (not maintenance) in 3L+ BRCAm or HRD+ OC, based on SOLO-3 (olaparib), QUADRA (niraparib), and ARIEL-4 (rucaparib) trials. National Comprehensive Cancer Network (NCCN) guidelines updated for ola and ruca. Low impact, as PARPi in later lines are limited due to use in 1L #gyncsm